For: | Phiri P, Engelthaler T, Carr H, Delanerolle G, Holmes C, Rathod S. Associated mortality risk of atypical antipsychotic medication in individuals with dementia. World J Psychiatry 2022; 12(2): 298-307 [PMID: 35317344 DOI: 10.5498/wjp.v12.i2.298] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v12/i2/298.htm |
Number | Citing Articles |
1 |
Shanquan Chen, Rudolf N. Cardinal, Kathryn Auckland, Stefan Gräf, John T. O’Brien, Benjamin R. Underwood. Risk Factors for Longer-Term Mortality in Discharged Patients with Dementia and SARS-CoV-2 Infection: A Matched Case-Control Study. Journal of Alzheimer's Disease 2023; 92(1): 295 doi: 10.3233/JAD-221093
|
2 |
Carlo Rossi, Nicole Campese, Carlo Colosimo. Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative review. Expert Opinion on Pharmacotherapy 2023; 24(13): 1415 doi: 10.1080/14656566.2023.2224501
|
3 |
亭 朱. Progress in the Treatment of Alzheimer’s Disease. Advances in Clinical Medicine 2023; 13(03): 3049 doi: 10.12677/ACM.2023.133433
|
4 |
Ana Todorovic, Philip Craig, Simon Pillinger, Panagiota Kontari, Sophie Gibbons, Luke Bryden, Tarso Franarin, Ceyda Uysal, Gloria Roque, Benjamin Fell. Akrivia Health Database—deep patient characterisation using a secondary mental healthcare dataset in England and Wales: cohort profile. BMJ Open 2024; 14(10): e088166 doi: 10.1136/bmjopen-2024-088166
|
5 |
Zhi-Peng Li, Yu-Shun You, Jun-Dong Wang, Lian-Ping He. Underlying disease may increase mortality risk in users of atypical antipsychotics. World Journal of Psychiatry 2022; 12(8): 1112-1114 doi: 10.5498/wjp.v12.i8.1112
|